Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,512.38 -3.89 -0.03%
TOPIX 1,171.40 -1.97 -0.17%
HANG SENG 22,760.24 64.23 0.28%

DaVita HealthCare Partners Announces New Chief Financial Officer



  DaVita HealthCare Partners Announces New Chief Financial Officer

Business Wire

DENVER -- July 8, 2013

DaVita HealthCare Partners Inc. (NYSE:DVA) announced today that Garry E.
Menzel, Ph.D., is to join the company in mid-September and become its Chief
Financial Officer. He will start as Senior Vice President, Finance, and begin
officially serving as the Chief Financial Officer the day after the company
files its Quarterly Report on Form 10-Q for the quarter ended September 30,
2013.

Menzel, 48, most recently held the positions of Chief Operating Officer and
Chief Financial Officer at Regulus Therapeutics Inc., a publicly-traded
biopharmaceutical company (NASDAQ: RGLS). Prior to joining Regulus in 2008, he
had a 14-year career on Wall Street where he was a Managing Director and
Global Head of Life Sciences for Credit Suisse and a Managing Director and
Global Head of Biotechnology for Goldman Sachs. Menzel also spent several
years as a strategy consultant for Bain & Company.

Menzel earned a B.Sc. with honors in biochemistry from the Imperial College of
Science & Technology in London, England, a Ph.D. in molecular biology from the
University of Cambridge, England, and a Masters in Business Administration
from the Stanford Graduate School of Business.

Jim Hilger, who has served as Interim Chief Financial Officer since 2012, and
Acting Chief Financial Officer from 2007 to 2008, will continue in his role as
the company’s Chief Accounting Officer, a position he has held since 2010.

“We believe we have found an executive with a versatile set of skills, from
advanced finance to demonstrated strategic capabilities,” said Kent Thiry,
Co-Chairman and Chief Executive Officer of DaVita HealthCare Partners. “Given
the nimbleness that is required for all healthcare providers we are excited to
have Garry join our leadership team.”

About DaVita HealthCare Partners

DaVita HealthCare Partners, a Fortune 500® company, is the parent company of
DaVita and HealthCare Partners. DaVita is a leading provider of kidney care in
the United States, delivering dialysis services to patients with chronic
kidney failure and end stage renal disease. As of March 31, 2013, DaVita
operated or provided administrative services at 1,991 outpatient dialysis
centers in the United States serving approximately 156,000 patients, and at 41
centers in eight countries outside of the United States. HealthCare Partners
manages and operates medical groups and affiliated physician networks in
California, Nevada, Florida and New Mexico in its pursuit to deliver
excellent-quality health care in a dignified and compassionate manner. As of
March 31, 2013, HealthCare Partners provided integrated care management for
approximately 742,000 managed care patients. For more information, please
visit DaVitaHealthCarePartners.com.

Contact:

DaVita HealthCare Partners Inc.
Investor Contact Information:
Jim Gustafson, 310-536-2585
Jim.gustafson@davita.com
or
Media Contact Information:
Skip Thurman, 303-876-6610
Skip.Thurman@davita.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement